nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzocaine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.109	0.167	CbGbCtD
Benzocaine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0982	0.151	CbGbCtD
Benzocaine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0847	0.131	CbGbCtD
Benzocaine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0823	0.127	CbGbCtD
Benzocaine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0744	0.115	CbGbCtD
Benzocaine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0744	0.115	CbGbCtD
Benzocaine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0713	0.11	CbGbCtD
Benzocaine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0552	0.085	CbGbCtD
Benzocaine—SCN11A—nerve—acquired immunodeficiency syndrome	0.0182	0.0912	CbGeAlD
Benzocaine—SCN8A—nerve—acquired immunodeficiency syndrome	0.0138	0.0691	CbGeAlD
Benzocaine—SCN10A—nerve—acquired immunodeficiency syndrome	0.00925	0.0462	CbGeAlD
Benzocaine—Cyanosis—Saquinavir—acquired immunodeficiency syndrome	0.00573	0.038	CcSEcCtD
Benzocaine—SCN11A—digestive system—acquired immunodeficiency syndrome	0.00531	0.0265	CbGeAlD
Benzocaine—Dermatitis contact—Indinavir—acquired immunodeficiency syndrome	0.00498	0.033	CcSEcCtD
Benzocaine—SCN11A—spinal cord—acquired immunodeficiency syndrome	0.00487	0.0243	CbGeAlD
Benzocaine—Dermatitis contact—Ritonavir—acquired immunodeficiency syndrome	0.00416	0.0276	CcSEcCtD
Benzocaine—Swelling—Indinavir—acquired immunodeficiency syndrome	0.00415	0.0275	CcSEcCtD
Benzocaine—SCN11A—nervous system—acquired immunodeficiency syndrome	0.0041	0.0205	CbGeAlD
Benzocaine—SCN11A—central nervous system—acquired immunodeficiency syndrome	0.00395	0.0197	CbGeAlD
Benzocaine—SCN7A—lung—acquired immunodeficiency syndrome	0.00377	0.0188	CbGeAlD
Benzocaine—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00375	0.0248	CcSEcCtD
Benzocaine—SCN8A—spinal cord—acquired immunodeficiency syndrome	0.00369	0.0185	CbGeAlD
Benzocaine—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.00324	0.0162	CbGeAlD
Benzocaine—SCN11A—brain—acquired immunodeficiency syndrome	0.00314	0.0157	CbGeAlD
Benzocaine—SCN8A—nervous system—acquired immunodeficiency syndrome	0.00311	0.0155	CbGeAlD
Benzocaine—SCN8A—central nervous system—acquired immunodeficiency syndrome	0.00299	0.015	CbGeAlD
Benzocaine—SCN9A—lung—acquired immunodeficiency syndrome	0.00295	0.0148	CbGeAlD
Benzocaine—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.00285	0.0142	CbGeAlD
Benzocaine—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00282	0.0187	CcSEcCtD
Benzocaine—CES1—digestive system—acquired immunodeficiency syndrome	0.00282	0.0141	CbGeAlD
Benzocaine—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.00279	0.0139	CbGeAlD
Benzocaine—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00273	0.0181	CcSEcCtD
Benzocaine—SCN10A—lymphoid tissue—acquired immunodeficiency syndrome	0.00272	0.0136	CbGeAlD
Benzocaine—CES1—blood—acquired immunodeficiency syndrome	0.00268	0.0134	CbGeAlD
Benzocaine—SCN7A—brain—acquired immunodeficiency syndrome	0.00267	0.0133	CbGeAlD
Benzocaine—SCN2A—blood—acquired immunodeficiency syndrome	0.00266	0.0133	CbGeAlD
Benzocaine—SCN7A—lymph node—acquired immunodeficiency syndrome	0.00258	0.0129	CbGeAlD
Benzocaine—SCN10A—blood—acquired immunodeficiency syndrome	0.00256	0.0128	CbGeAlD
Benzocaine—SCN2A—spinal cord—acquired immunodeficiency syndrome	0.00256	0.0128	CbGeAlD
Benzocaine—SCN1A—lung—acquired immunodeficiency syndrome	0.00254	0.0127	CbGeAlD
Benzocaine—SCN10A—spinal cord—acquired immunodeficiency syndrome	0.00247	0.0123	CbGeAlD
Benzocaine—SCN2A—vagina—acquired immunodeficiency syndrome	0.00246	0.0123	CbGeAlD
Benzocaine—SCN5A—digestive system—acquired immunodeficiency syndrome	0.00245	0.0122	CbGeAlD
Benzocaine—SCN4A—nervous system—acquired immunodeficiency syndrome	0.00244	0.0122	CbGeAlD
Benzocaine—SCN8A—brain—acquired immunodeficiency syndrome	0.00238	0.0119	CbGeAlD
Benzocaine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00237	0.0157	CcSEcCtD
Benzocaine—CES1—lung—acquired immunodeficiency syndrome	0.00235	0.0118	CbGeAlD
Benzocaine—SCN1A—nervous system—acquired immunodeficiency syndrome	0.00235	0.0118	CbGeAlD
Benzocaine—SCN4A—central nervous system—acquired immunodeficiency syndrome	0.00235	0.0117	CbGeAlD
Benzocaine—SCN3A—blood—acquired immunodeficiency syndrome	0.00234	0.0117	CbGeAlD
Benzocaine—SCN5A—blood—acquired immunodeficiency syndrome	0.00233	0.0116	CbGeAlD
Benzocaine—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.0153	CcSEcCtD
Benzocaine—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.00226	0.0113	CbGeAlD
Benzocaine—SCN3A—bone marrow—acquired immunodeficiency syndrome	0.00226	0.0113	CbGeAlD
Benzocaine—SCN3A—spinal cord—acquired immunodeficiency syndrome	0.00225	0.0113	CbGeAlD
Benzocaine—SCN10A—lung—acquired immunodeficiency syndrome	0.00225	0.0112	CbGeAlD
Benzocaine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.0148	CcSEcCtD
Benzocaine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00219	0.0145	CcSEcCtD
Benzocaine—CES1—nervous system—acquired immunodeficiency syndrome	0.00218	0.0109	CbGeAlD
Benzocaine—SCN3A—vagina—acquired immunodeficiency syndrome	0.00217	0.0108	CbGeAlD
Benzocaine—SCN5A—vagina—acquired immunodeficiency syndrome	0.00216	0.0108	CbGeAlD
Benzocaine—SCN2A—nervous system—acquired immunodeficiency syndrome	0.00216	0.0108	CbGeAlD
Benzocaine—CES1—central nervous system—acquired immunodeficiency syndrome	0.0021	0.0105	CbGeAlD
Benzocaine—SCN9A—brain—acquired immunodeficiency syndrome	0.00209	0.0104	CbGeAlD
Benzocaine—SCN10A—nervous system—acquired immunodeficiency syndrome	0.00208	0.0104	CbGeAlD
Benzocaine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00208	0.0138	CcSEcCtD
Benzocaine—SCN2A—central nervous system—acquired immunodeficiency syndrome	0.00208	0.0104	CbGeAlD
Benzocaine—SCN3A—lung—acquired immunodeficiency syndrome	0.00205	0.0102	CbGeAlD
Benzocaine—SCN9A—lymph node—acquired immunodeficiency syndrome	0.00202	0.0101	CbGeAlD
Benzocaine—SCN10A—central nervous system—acquired immunodeficiency syndrome	0.002	0.01	CbGeAlD
Benzocaine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00199	0.0132	CcSEcCtD
Benzocaine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00199	0.0132	CcSEcCtD
Benzocaine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00199	0.0132	CcSEcCtD
Benzocaine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00195	0.0129	CcSEcCtD
Benzocaine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.0128	CcSEcCtD
Benzocaine—SCN3A—nervous system—acquired immunodeficiency syndrome	0.0019	0.00948	CbGeAlD
Benzocaine—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00189	0.00945	CbGeAlD
Benzocaine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00189	0.0125	CcSEcCtD
Benzocaine—SCN4A—brain—acquired immunodeficiency syndrome	0.00186	0.00932	CbGeAlD
Benzocaine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00183	0.0121	CcSEcCtD
Benzocaine—SCN3A—central nervous system—acquired immunodeficiency syndrome	0.00183	0.00913	CbGeAlD
Benzocaine—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.00182	0.0091	CbGeAlD
Benzocaine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00181	0.012	CcSEcCtD
Benzocaine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.0018	0.0119	CcSEcCtD
Benzocaine—SCN1A—brain—acquired immunodeficiency syndrome	0.0018	0.00898	CbGeAlD
Benzocaine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00177	0.0117	CcSEcCtD
Benzocaine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.0117	CcSEcCtD
Benzocaine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00177	0.0117	CcSEcCtD
Benzocaine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00177	0.0117	CcSEcCtD
Benzocaine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00177	0.0117	CcSEcCtD
Benzocaine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00174	0.0115	CcSEcCtD
Benzocaine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.0114	CcSEcCtD
Benzocaine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00172	0.00857	CbGeAlD
Benzocaine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0017	0.0112	CcSEcCtD
Benzocaine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00169	0.0112	CcSEcCtD
Benzocaine—CES1—brain—acquired immunodeficiency syndrome	0.00166	0.00832	CbGeAlD
Benzocaine—SCN2A—brain—acquired immunodeficiency syndrome	0.00165	0.00824	CbGeAlD
Benzocaine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.0109	CcSEcCtD
Benzocaine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00164	0.0109	CcSEcCtD
Benzocaine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00163	0.0108	CcSEcCtD
Benzocaine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.0108	CcSEcCtD
Benzocaine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00161	0.0107	CcSEcCtD
Benzocaine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00161	0.0107	CcSEcCtD
Benzocaine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00161	0.0107	CcSEcCtD
Benzocaine—CES1—lymph node—acquired immunodeficiency syndrome	0.00161	0.00804	CbGeAlD
Benzocaine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.0016	0.0106	CcSEcCtD
Benzocaine—SCN10A—brain—acquired immunodeficiency syndrome	0.00159	0.00795	CbGeAlD
Benzocaine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00158	0.0105	CcSEcCtD
Benzocaine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00157	0.0104	CcSEcCtD
Benzocaine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00155	0.0103	CcSEcCtD
Benzocaine—SCN10A—lymph node—acquired immunodeficiency syndrome	0.00154	0.00768	CbGeAlD
Benzocaine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.0102	CcSEcCtD
Benzocaine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.01	CcSEcCtD
Benzocaine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00996	CcSEcCtD
Benzocaine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00145	0.00962	CcSEcCtD
Benzocaine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00145	0.00961	CcSEcCtD
Benzocaine—SCN3A—brain—acquired immunodeficiency syndrome	0.00145	0.00725	CbGeAlD
Benzocaine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.0096	CcSEcCtD
Benzocaine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00958	CcSEcCtD
Benzocaine—SCN5A—brain—acquired immunodeficiency syndrome	0.00145	0.00723	CbGeAlD
Benzocaine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00946	CcSEcCtD
Benzocaine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00141	0.00932	CcSEcCtD
Benzocaine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00141	0.00931	CcSEcCtD
Benzocaine—Rash—Stavudine—acquired immunodeficiency syndrome	0.0014	0.00929	CcSEcCtD
Benzocaine—SCN3A—lymph node—acquired immunodeficiency syndrome	0.0014	0.007	CbGeAlD
Benzocaine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0014	0.00928	CcSEcCtD
Benzocaine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00138	0.00915	CcSEcCtD
Benzocaine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00138	0.00915	CcSEcCtD
Benzocaine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00914	CcSEcCtD
Benzocaine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00906	CcSEcCtD
Benzocaine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00894	CcSEcCtD
Benzocaine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00888	CcSEcCtD
Benzocaine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00878	CcSEcCtD
Benzocaine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00855	CcSEcCtD
Benzocaine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00855	CcSEcCtD
Benzocaine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00843	CcSEcCtD
Benzocaine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00829	CcSEcCtD
Benzocaine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00815	CcSEcCtD
Benzocaine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00122	0.00808	CcSEcCtD
Benzocaine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00122	0.00807	CcSEcCtD
Benzocaine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00796	CcSEcCtD
Benzocaine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00793	CcSEcCtD
Benzocaine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00791	CcSEcCtD
Benzocaine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.00762	CcSEcCtD
Benzocaine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00761	CcSEcCtD
Benzocaine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00113	0.00751	CcSEcCtD
Benzocaine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00113	0.0075	CcSEcCtD
Benzocaine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00734	CcSEcCtD
Benzocaine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00726	CcSEcCtD
Benzocaine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.0071	CcSEcCtD
Benzocaine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00709	CcSEcCtD
Benzocaine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00706	CcSEcCtD
Benzocaine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00705	CcSEcCtD
Benzocaine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00679	CcSEcCtD
Benzocaine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00678	CcSEcCtD
Benzocaine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00678	CcSEcCtD
Benzocaine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00674	CcSEcCtD
Benzocaine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000976	0.00647	CcSEcCtD
Benzocaine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000947	0.00628	CcSEcCtD
Benzocaine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000947	0.00627	CcSEcCtD
Benzocaine—ABCB1—retina—acquired immunodeficiency syndrome	0.000939	0.0047	CbGeAlD
Benzocaine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000912	0.00604	CcSEcCtD
Benzocaine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000911	0.00604	CcSEcCtD
Benzocaine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00087	0.00577	CcSEcCtD
Benzocaine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000869	0.00576	CcSEcCtD
Benzocaine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000668	0.00334	CbGeAlD
Benzocaine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00066	0.0033	CbGeAlD
Benzocaine—ABCB1—blood—acquired immunodeficiency syndrome	0.000628	0.00314	CbGeAlD
Benzocaine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000608	0.00304	CbGeAlD
Benzocaine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000605	0.00303	CbGeAlD
Benzocaine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000583	0.00291	CbGeAlD
Benzocaine—ABCB1—lung—acquired immunodeficiency syndrome	0.000551	0.00275	CbGeAlD
Benzocaine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00051	0.00255	CbGeAlD
Benzocaine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00245	CbGeAlD
Benzocaine—ABCB1—brain—acquired immunodeficiency syndrome	0.00039	0.00195	CbGeAlD
Benzocaine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000377	0.00188	CbGeAlD
